Literature DB >> 32005436

Diagnosis of Mesothelioma.

Daffolyn Rachael Fels Elliott1, Kirk D Jones2.   

Abstract

Mesothelioma is a rare neoplasm that arises from mesothelial cells lining body cavities including the pleura, pericardium, peritoneum, and tunica vaginalis. Most malignant mesotheliomas occur in the chest and are frequently associated with a history of asbestos exposure. The diagnosis of malignant mesothelioma is challenging and fraught with pitfalls, particularly in small biopsies. This article highlights what the pathologist needs to know regarding the clinical and radiographic presentation of mesothelioma, histologic features including subtypes and variants, and recent advances in immunohistochemical markers and molecular testing.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Epithelioid; Mesothelioma; Pleural effusion; Reactive mesothelial proliferation; Sarcomatoid

Mesh:

Year:  2019        PMID: 32005436     DOI: 10.1016/j.path.2019.10.001

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  8 in total

1.  A survivor woman after three years of a cardiac tamponade.

Authors:  Ana Lilia Peralta-Amaro; Adriana Vázquez-Hernández; Guadalupe Morales-Osorio; Emily Pecero-García; Salma Triana-González; Fernanda Manzo-Carballo; Elsa Acosta-Jiménez
Journal:  J Cardiol Cases       Date:  2021-11-22

2.  Identification of Potential Antigens for Developing mRNA Vaccine for Immunologically Cold Mesothelioma.

Authors:  Shichao Zhang; Shuqin Li; Ya Wei; Yu Xiong; Qin Liu; Zuquan Hu; Zhu Zeng; Fuzhou Tang; Yan Ouyang
Journal:  Front Cell Dev Biol       Date:  2022-07-01

3.  Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report).

Authors:  Irene Dell'Anno; Elisa Barone; Luciano Mutti; Doris M Rassl; Stefan J Marciniak; Roberto Silvestri; Stefano Landi; Federica Gemignani
Journal:  J Transl Med       Date:  2020-09-04       Impact factor: 5.531

4.  Epigenetic Immune Remodeling of Mesothelioma Cells: A New Strategy to Improve the Efficacy of Immunotherapy.

Authors:  Maria Fortunata Lofiego; Sara Cannito; Carolina Fazio; Francesca Piazzini; Ornella Cutaia; Laura Solmonese; Francesco Marzani; Carla Chiarucci; Anna Maria Di Giacomo; Luana Calabrò; Sandra Coral; Michele Maio; Alessia Covre
Journal:  Epigenomes       Date:  2021-12-14

5.  Prognostic Bone Metastasis-Associated Immune-Related Genes Regulated by Transcription Factors in Mesothelioma.

Authors:  Zhiquan Hao; Siqiao Wang; Zixuan Zheng; Jiehan Li; Wanting Fu; Donglin Han; Yinrou Huang; Qing Lin; Shuyuan Xian; Penghui Yan; Man Li; Ruoyi Lin; Tong Meng; Jie Zhang; Zongqiang Huang
Journal:  Biomed Res Int       Date:  2022-01-27       Impact factor: 3.411

6.  Mesothelioma in a developing country: a retrospective analysis of the diagnostic process.

Authors:  Paulo Henrique Peitl Gregório; Ricardo Mingarini Terra; Leonardo Pontual Lima; Paulo Manuel Pêgo-Fernandes
Journal:  J Bras Pneumol       Date:  2022-08-19       Impact factor: 2.800

7.  Malignant peritoneal mesothelioma: correlation between CT imaging features and histologic subtypes.

Authors:  Isha D Atre; Gaurav V Watane; Mukesh G Harisinghani
Journal:  Abdom Radiol (NY)       Date:  2021-08-03

8.  "Omental Cake" in a Patient With Asbestosis Leading to the Diagnosis of Malignant Peritoneal Mesothelioma.

Authors:  Alejandro García Martínez; Inmaculada Pavón Guerrero; Lidia Campos Gonzaga
Journal:  Cureus       Date:  2021-05-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.